Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
News
Die not yet cast for lymphazurin and methylene blue dye
Publish date:
December 4, 2015
AT THE ACS CLINICAL CONGRESS
References
pwendling@frontlinemedcom.com
Pages
« first
1
2
Recommended Reading
VIDEO: When to use MRI in breast cancer
MDedge Hematology and Oncology
Better outcomes with open surgery vs. laparoscopic for rectal cancer
MDedge Hematology and Oncology
VIDEO: Immediate breast reconstruction results reassuring in select patients
MDedge Hematology and Oncology
VIDEO: Tomosynthesis soon to be standard of care for breast cancer screening
MDedge Hematology and Oncology
Self-assessed mental health scores tied to radical cystectomy complications
MDedge Hematology and Oncology
Delayed diagnosis tops breast cancer malpractice claims
MDedge Hematology and Oncology
Blacks receive inferior care for localized prostate cancer
MDedge Hematology and Oncology
Tomotherapy may decrease radiation-induced bowel toxicity in cervical cancer
MDedge Hematology and Oncology
Decision model shows prophylactic double mastectomy more costly to patients
MDedge Hematology and Oncology
Readmission after esophagectomy raises mortality
MDedge Hematology and Oncology
Breast Cancer
All Specialties
